Summit looks to repeat ivo's Chinese success
Akeso scored in the Harmoni-A trial, and now Summit must do the same in Harmoni.
MacroGenics cuts down its Tamarack
Vobra-duo is discontinued at long last.
Elevation goes down on Claudin disaster
The honeymoon is over for Claudin18.2, as Elevation drops EO-3021.
How to be different in in vivo Car-T
After Astra's EsoBiotec takeover the battle for uniqueness begins.
Make or break time for Caribou
The company’s matching strategy for CB-010 will soon be put to the test.
